ARTerial EMbolization for haemorrhoIdal Disease (ART.EM.I. Study)

Launched by OXFORD UNIVERSITY HOSPITALS NHS TRUST · Dec 21, 2020

Keywords

ClinConnect Summary

This is a pilot, prospective, single arm and single centre trial to assess the safety and efficacy of haemorrhoid embolisation. Patients with advanced hemorrhoidal disease (grade II-IV) will be identified through the colorectal clinic with a recruitment target of 24 patients. The duration of patient participation in this study is 24 months. During this time the patient will have to attend 4 appointments (including the treatment session).

All cases in this study will be performed as day case procedures. The patients will be admitted to the interventional radiology day unit in the morning, w...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • i. Adult male and female patients between the ages of 40-90 years old.
• • ii. Patients with grade II-IV haemorrhoid disease with re-current or active bleeding AND
• • iii. Patients with (ii) who do not wish to undergo surgery for their symptoms OR
• • iv. Patients with (ii) despite previous surgery.
• • v. Patients who can understand and sign the consent form.
• Exclusion Criteria:
• • i. Patients who are not otherwise fit for surgery.
• • ii. Patients with significant ano-rectal comorbidities (cancer, fistula, abscesses).
• • iii. Patients who are unable to sign the inform consent form.
• • iv. Pregnancy.
• • v. Patients with history of significant colorectal disease or previous colectomy.
• • vi. Iodine allergy/ Contrast allergy.